ToolGen licenses CRISPR/Cas9 technology to Thermo Fisher Scientific
16 March, 2015Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits.
BeiGene chooses CHOZN for oncology drug development
16 March, 2015 | Supplied by: MerckOncology company BeiGene has purchased SAFC's off-the-shelf, turnkey CHOZN cell line production platform and cell line engineering services to support discovery and commercial development of BeiGene's targeted oncology drug.
ToolGen licenses CRISPR/Cas9 technology to Thermo Fisher Scientific
16 March, 2015Korean biotechnology company ToolGen will license its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. Thermo Fisher will utilise the technology to develop and market CRISPR reagent kits.
Single donor's blood cells to test side effects of drugs
11 March, 2015UK researchers are using combinations of cells from a single donor's blood to predict whether a new drug will cause a severe immune reaction in humans.
Single donor's blood cells to test side effects of drugs
11 March, 2015UK researchers are using combinations of cells from a single donor's blood to predict whether a new drug will cause a severe immune reaction in humans.
Biomarker-selected clinical trial supported by RNA detection technology
10 March, 2015 | Supplied by: Australian BiosearchMerrimack Pharmaceuticals is utilising RNAscope technology, from Advanced Cell Diagnostics (ACD), to select patients for its Phase 2 clinical trial of its product candidate MM-121.
Probiotic reduces weight gain in mice
09 March, 2015In a landmark probiotic study, European researchers have demonstrated the effect of a particular probiotic strain on body fat mass and glucose tolerance.
Bio-Rad PrimePCR Assays for model organism genomes
06 March, 2015 | Supplied by: Bio-Rad Laboratories Pty LtdBio-Rad Laboratories has launched predesigned PrimePCR Assays for six of the most common model organism genomes used for gene expression analysis: rhesus monkey, zebrafish, yeast, cow, rabbit and pig.
Easily untangling DNA
05 March, 2015Belgian researchers have discovered a simple and effective way to untangle DNA, enabling its straightened-out structure to be studied under a microscope.
Agilent Technologies HaloPlexHS Target Enrichment System
05 March, 2015 | Supplied by: Agilent Technologies Australia Pty LtdAgilent Technologies has launched the HaloPlexHS target enrichment system, designed to improve the speed and accuracy of clinical cancer research. The product will enable researchers to rapidly and accurately identify disease-associated variants in tumour samples - information that can be vital to research in cancer treatments.
SSI PCR range
04 March, 2015 | Supplied by: Interpath Services Pty LtdThe SSI range of PCR products allows users to amplify their results.
Agilent Technologies ClearSeq Comprehensive Cancer research panel
04 March, 2015
Agilent Technologies has launched the ClearSeq Comprehensive Cancer research panel, designed to improve the speed and accuracy of clinical cancer research. The product will enable researchers to rapidly and accurately identify disease-associated variants in tumour samples - information that can be vital to research in cancer treatments.
Agilent Technologies ClearSeq Comprehensive Cancer research panel
04 March, 2015 | Supplied by: Agilent Technologies Australia Pty LtdAgilent Technologies has launched the ClearSeq Comprehensive Cancer research panel, designed to improve the speed and accuracy of clinical cancer research. The product will enable researchers to rapidly and accurately identify disease-associated variants in tumour samples - information that can be vital to research in cancer treatments.
Agilent Technologies OneSeq target enrichment for next-generation sequencing
03 March, 2015 | Supplied by: Agilent Technologies Australia Pty LtdAgilent Technologies has introduced OneSeq, an all-in-one target enrichment product for next-generation sequencing. The product is designed to detect and analyse copy number variations, loss of heterozygosity and mutations in a single reaction for use in constitutional disease research.
A more sensitive peanut allergy test
02 March, 2015Chemists at the University of Connecticut have developed a peanut allergy test which is said to be far more sensitive than current procedures. It is hoped that the blood test will be better able to diagnose the severity of an individual's allergic reaction.
